Provider review
Options Medical Weight Loss review
Medication is inside every figure, and it disclaims affiliation with the brand makers.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
$199/mo semaglutide and $399/mo tirzepatide, medication included
Visit Options Medical Weight LossThe step from semaglutide to tirzepatide here is a full doubling, wider than most.
Price as published
Options Medical Weight Loss
$199/mo semaglutide and $399/mo tirzepatide, medication included
- Vs median
- $24/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The medication is inside the number on every line and each card says so, which puts this ahead of the membership-plus-drug structures common in this category. It also carries a disclaimer worth noting: an explicit statement that the company is not affiliated with the two manufacturers of the branded products, printed under the products rather than buried in the terms. Compounded sellers borrow the reputation of those brands constantly, and most leave the distinction for you to work out. Stating it is the better behavior and it is not common. The pricing has one feature to flag before starting. The gap between the two molecules here is a full doubling, where a third to a half is the usual spread, so if you expect to move from semaglutide to tirzepatide you should price that step now rather than discover it later. All three figures are floors, and no milligram is published against any of them.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want the medication included in the advertised figure
- You value a provider stating plainly what it is not affiliated with
- You may not qualify for a GLP-1 and want a non-GLP-1 option priced alongside
Look elsewhere if
- You expect to move to tirzepatide — the step here is a doubling
- You want a published price at a working dose rather than a floor
- You want a dose behind the number
What it actually costs
Price as published
$199/mo semaglutide and $399/mo tirzepatide, medication included
- Vs median
- $24/mo above the $175 median across the 299 of 548 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. Medication is included in every figure and said so on every card, plus an explicit disclaimer of affiliation with the brand manufacturers — both good behavior. For a reader planning to move molecules the step matters more than the entry price: tirzepatide is double semaglutide here, wider than the usual spread. No low-dose product, no dose published, and all three figures are floors.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- Medication is included in every advertised figure, stated on each card.
- Explicitly disclaims affiliation with the brand-name manufacturers.
- A non-GLP-1 option is priced alongside, for readers who do not qualify or do not want one.
Pharmacy, labs and oversight
Options Medical Weight Loss does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Options Medical Weight Loss publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
The medication is inside the number on every line and the card says so, which puts this ahead of the membership-plus-drug structures elsewhere on the page. It also carries a disclaimer that deserves noting: an explicit statement that the company is not affiliated with the two manufacturers of the branded products, printed under the products rather than buried in terms. Compounded sellers borrow the reputation of the brands constantly and most leave the distinction to the reader; stating it is the better behavior. The pricing itself has one feature worth flagging. The gap between the two molecules here is a full doubling, which is wider than the third-to-half spread common in this category, so anyone expecting to move from semaglutide to tirzepatide should price that step before starting rather than after. All three figures are floors, and no milligram is published against any of them.
The honest cons
The tirzepatide figure is double the semaglutide one, a wider step than most.
- All three prices are floors with no rung above them published.
- No milligram appears against any figure.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Options Medical Weight Loss is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way Options Medical Weight Loss does. Both are partners: we may earn a commission if you start care through these links.
Partner
Sprout Health
$149 sema · $199 tirz
Standard plan, self-directed low dose
FDA warning letter · Sprout Health · September 2025 · addressed to Sprout Health Partners LLC dba Sprout Health. Details in our review.
Partner
Bodybuilding Health+
$179/mo sema · $209/mo tirz
Standard plan, self-directed low dose
Where this sits
#310 of 548
Ordered with the companies that pay us first, and Options Medical Weight Loss is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
HealthRX
$190/mo sema · $239/mo tirz (monthly plan)
- Vs median
- $15/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the HealthRX review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.